CME and CFTC Engage in Heated Battle Over On-Chain Perpetual Futures

The conflict between the CME Group and the U.S. Commodity Futures Trading Commission (CFTC) has escalated, with the CME suing the CFTC over its decision to allow blockchain-based perpetual future products. The CME argues that these products, which enable users to speculate on asset prices with leverage and no expiration date, are harmful to its traditional futures products and that the CFTC's approval did not consider the potential consequences. The CFTC, on the other hand, believes that its approach will foster innovation and competition in the rapidly growing market. The dispute has significant implications for the U.S. approach to regulating perpetual futures, with non-U.S. volume reportedly reaching $60 trillion last year. The CME claims that the CFTC is mislabeling the products and misapplying the law, as futures require an end date, whereas perpetual futures do not. The lawsuit argues that the CFTC's sudden embrace of perpetual futures did not consider the potential harm to traditional futures products. The tension between the two entities has been mounting, particularly since the start of the Iran conflict, which saw a surge in interest in perpetual contracts on oil prices traded on offshore decentralized finance (DeFi) exchanges. The CFTC's reforming agenda has been met with frustration from some quarters, with critics arguing that the regulator is not considering the potential consequences of its actions. The CME's attempt to fast-track 24/7 trading for crude oil futures was blocked by the CFTC, further exacerbating the dispute. The CME's chairman, Terry Duffy, has been vocal in his criticism of the CFTC's approach, arguing that the regulator is not following the proper protocol and that the products are not being properly policed. The CFTC's chairman, Mike Selig, has declined to comment on the matter, but has stated that the CME's decision to disregard the regulator's efforts to undertake a reasoned analysis of the issues is 'wholly inappropriate.' The dispute has significant implications for the future of perpetual futures in the U.S. and will likely be closely watched by market participants and regulators alike. The CME's stance on crypto perpetual futures has been viewed by some as typical of the way large incumbents handle innovation that might threaten their dominance. The issue is not whether the CME is pro or anti-crypto, but rather an incumbent using regulation to hold off competition. The future of CFTC-driven perps remains uncertain as the CME readies its case, which includes claims that the agency rubber-stamped the Kalshi application. The CFTC's approach to regulating perpetual futures has been criticized by some, who argue that the regulator is not following the proper protocol and that the products are not being properly policed. The dispute highlights the challenges of regulating innovative financial products and the need for clear and consistent guidance from regulators.